Harrow to Announce Third Quarter 2022 Financial Results on November 14, 2022
October 28 2022 - 8:00AM
Business Wire
Harrow (Nasdaq: HROW), an eyecare pharmaceutical company
exclusively focused on the discovery, development, and
commercialization of innovative ophthalmic therapies, today
announced that it will release its financial results for the third
quarter ended September 30, 2022, on Monday, November 14, 2022,
after the market close. The Company will also post its third
quarter Letter to Stockholders to the “Investors” section of its
website, harrowinc.com. Harrow will host a conference call and live
webcast at 4:45 p.m. Eastern Time to discuss the results and
provide a business update.
Conference Call Details:
Date:
Monday, November 14, 2022
Time:
4:45 p.m. Eastern time
Participant Dial-in:
1-833-953-2434 (U.S.) 1-412-317-5763
(International)
Replay Dial-in (Passcode
7735845):
(telephonic replay through November 21,
2022)
1-877-344-7529 (U.S.) 1-412-317-0088
(International)
Webcast: (online replay through
February 14, 2023)
harrowinc.com
About Harrow
Harrow (Nasdaq: HROW) is an eyecare pharmaceutical company
exclusively focused on the discovery, development, and
commercialization of innovative ophthalmic therapies that are
accessible and affordable. For more information about Harrow,
including investor-related materials, please visit the corporate
website, harrowinc.com, or Harrow’s LinkedIn page.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221027005179/en/
Jamie Webb, Director of Communications and Investor Relations
jwebb@harrowinc.com 615-733-4737
Harrow (NASDAQ:HROW)
Historical Stock Chart
From Aug 2024 to Sep 2024
Harrow (NASDAQ:HROW)
Historical Stock Chart
From Sep 2023 to Sep 2024